nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP1A1—Quinine—malaria	0.0501	0.0683	CbGbCtD
Dapagliflozin—CYP1A1—Quinidine—malaria	0.044	0.06	CbGbCtD
Dapagliflozin—CYP3A4—Clindamycin—malaria	0.0396	0.054	CbGbCtD
Dapagliflozin—CYP2C9—Pyrimethamine—malaria	0.0392	0.0534	CbGbCtD
Dapagliflozin—CYP2C9—Sulfadiazine—malaria	0.0392	0.0534	CbGbCtD
Dapagliflozin—CYP2D6—Pyrimethamine—malaria	0.0358	0.0488	CbGbCtD
Dapagliflozin—CYP1A2—Proguanil—malaria	0.0347	0.0474	CbGbCtD
Dapagliflozin—CYP2C9—Artemether—malaria	0.0333	0.0454	CbGbCtD
Dapagliflozin—CYP2C9—Proguanil—malaria	0.0313	0.0427	CbGbCtD
Dapagliflozin—CYP2D6—Artemether—malaria	0.0304	0.0415	CbGbCtD
Dapagliflozin—CYP2D6—Proguanil—malaria	0.0286	0.039	CbGbCtD
Dapagliflozin—CYP2D6—Quinidine barbiturate—malaria	0.0271	0.037	CbGbCtD
Dapagliflozin—CYP1A2—Pentoxifylline—malaria	0.025	0.034	CbGbCtD
Dapagliflozin—CYP3A4—Sulfadiazine—malaria	0.0228	0.031	CbGbCtD
Dapagliflozin—CYP1A2—Quinine—malaria	0.0224	0.0305	CbGbCtD
Dapagliflozin—CYP2C9—Quinine—malaria	0.0202	0.0275	CbGbCtD
Dapagliflozin—CYP1A2—Quinidine—malaria	0.0197	0.0268	CbGbCtD
Dapagliflozin—ABCB1—Quinine—malaria	0.0196	0.0267	CbGbCtD
Dapagliflozin—CYP3A4—Artemether—malaria	0.0194	0.0264	CbGbCtD
Dapagliflozin—CYP2D6—Quinine—malaria	0.0184	0.0251	CbGbCtD
Dapagliflozin—CYP3A4—Proguanil—malaria	0.0182	0.0248	CbGbCtD
Dapagliflozin—Vulvitis—Clindamycin—malaria	0.0178	0.133	CcSEcCtD
Dapagliflozin—CYP2C9—Quinidine—malaria	0.0177	0.0242	CbGbCtD
Dapagliflozin—CYP3A4—Doxycycline—malaria	0.0173	0.0235	CbGbCtD
Dapagliflozin—ABCB1—Quinidine—malaria	0.0172	0.0235	CbGbCtD
Dapagliflozin—CYP2D6—Quinidine—malaria	0.0162	0.0221	CbGbCtD
Dapagliflozin—CYP2C9—Dapsone—malaria	0.0153	0.0208	CbGbCtD
Dapagliflozin—SLC5A4—blood plasma—malaria	0.0142	0.144	CbGeAlD
Dapagliflozin—CYP3A4—Quinine—malaria	0.0117	0.016	CbGbCtD
Dapagliflozin—SLC5A2—blood plasma—malaria	0.0108	0.109	CbGeAlD
Dapagliflozin—CYP3A4—Quinidine—malaria	0.0103	0.0141	CbGbCtD
Dapagliflozin—Vulvovaginitis—Clindamycin—malaria	0.00958	0.0714	CcSEcCtD
Dapagliflozin—CYP3A4—Dapsone—malaria	0.00889	0.0121	CbGbCtD
Dapagliflozin—SLC5A4—kidney—malaria	0.00644	0.0651	CbGeAlD
Dapagliflozin—Diuresis—Sulfadiazine—malaria	0.00642	0.0478	CcSEcCtD
Dapagliflozin—SLC5A4—digestive system—malaria	0.00547	0.0553	CbGeAlD
Dapagliflozin—SLC5A2—kidney—malaria	0.00488	0.0494	CbGeAlD
Dapagliflozin—SLC5A11—blood—malaria	0.00473	0.0478	CbGeAlD
Dapagliflozin—Haemolysis—Quinine—malaria	0.00457	0.0341	CcSEcCtD
Dapagliflozin—Haemolysis—Quinidine—malaria	0.00457	0.0341	CcSEcCtD
Dapagliflozin—Haemolysis—Quinidine barbiturate—malaria	0.00413	0.0308	CcSEcCtD
Dapagliflozin—SLC5A2—blood—malaria	0.00395	0.0399	CbGeAlD
Dapagliflozin—SLC5A1—kidney—malaria	0.0037	0.0374	CbGeAlD
Dapagliflozin—SLC5A4—brain—malaria	0.00323	0.0327	CbGeAlD
Dapagliflozin—SLC5A1—digestive system—malaria	0.00314	0.0317	CbGeAlD
Dapagliflozin—SLC5A11—brain—malaria	0.00293	0.0297	CbGeAlD
Dapagliflozin—Vulvovaginal candidiasis—Clindamycin—malaria	0.00282	0.021	CcSEcCtD
Dapagliflozin—Vulvovaginal mycotic infection—Clindamycin—malaria	0.00271	0.0202	CcSEcCtD
Dapagliflozin—UGT1A9—kidney—malaria	0.00233	0.0235	CbGeAlD
Dapagliflozin—UGT2B4—liver—malaria	0.00215	0.0218	CbGeAlD
Dapagliflozin—UGT1A9—digestive system—malaria	0.00198	0.02	CbGeAlD
Dapagliflozin—Fungal infection—Clindamycin—malaria	0.00192	0.0143	CcSEcCtD
Dapagliflozin—UGT2B7—kidney—malaria	0.00188	0.019	CbGeAlD
Dapagliflozin—Polyuria—Sulfadiazine—malaria	0.00165	0.0123	CcSEcCtD
Dapagliflozin—UGT2B7—digestive system—malaria	0.00159	0.0161	CbGeAlD
Dapagliflozin—CYP1A2—blood plasma—malaria	0.00156	0.0158	CbGeAlD
Dapagliflozin—SLC5A11—NRF2 pathway—G6PD—malaria	0.00153	0.0458	CbGpPWpGaD
Dapagliflozin—Extravasation—Quinidine barbiturate—malaria	0.0015	0.0112	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Sulfadiazine—malaria	0.00148	0.011	CcSEcCtD
Dapagliflozin—CYP2C9—blood plasma—malaria	0.00148	0.015	CbGeAlD
Dapagliflozin—UGT1A9—liver—malaria	0.00147	0.0149	CbGeAlD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00143	0.0427	CbGpPWpGaD
Dapagliflozin—Vaginal infection—Clindamycin—malaria	0.0014	0.0104	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Pyrimethamine—malaria	0.00137	0.0102	CcSEcCtD
Dapagliflozin—Malnutrition—Proguanil—malaria	0.00131	0.00977	CcSEcCtD
Dapagliflozin—UGT2B7—liver—malaria	0.00119	0.012	CbGeAlD
Dapagliflozin—CYP3A4—blood plasma—malaria	0.00113	0.0114	CbGeAlD
Dapagliflozin—SLC5A4—NRF2 pathway—G6PD—malaria	0.00112	0.0334	CbGpPWpGaD
Dapagliflozin—CYP2D6—blood plasma—malaria	0.00111	0.0112	CbGeAlD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00111	0.00826	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Quinidine—malaria	0.00108	0.00806	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Quinine—malaria	0.00108	0.00806	CcSEcCtD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00104	0.0312	CbGpPWpGaD
Dapagliflozin—Skin disorder—Proguanil—malaria	0.00104	0.00774	CcSEcCtD
Dapagliflozin—Hypersensitivity—Pyrimethamine—malaria	0.00101	0.00754	CcSEcCtD
Dapagliflozin—Thirst—Pentoxifylline—malaria	0.000999	0.00744	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Dapsone—malaria	0.000994	0.00741	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Quinidine barbiturate—malaria	0.000976	0.00727	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Quinidine—malaria	0.000964	0.00718	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Quinine—malaria	0.000964	0.00718	CcSEcCtD
Dapagliflozin—Influenza—Dapsone—malaria	0.000961	0.00716	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Proguanil—malaria	0.000923	0.00688	CcSEcCtD
Dapagliflozin—Angina pectoris—Quinidine—malaria	0.000888	0.00662	CcSEcCtD
Dapagliflozin—Angina pectoris—Quinine—malaria	0.000888	0.00662	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Quinidine barbiturate—malaria	0.00087	0.00648	CcSEcCtD
Dapagliflozin—Dysuria—Clindamycin—malaria	0.000869	0.00648	CcSEcCtD
Dapagliflozin—CYP1A2—hematopoietic system—malaria	0.000862	0.00872	CbGeAlD
Dapagliflozin—CYP1A1—hematopoietic system—malaria	0.00085	0.0086	CbGeAlD
Dapagliflozin—CYP2A6—liver—malaria	0.00085	0.0086	CbGeAlD
Dapagliflozin—Body temperature increased—Proguanil—malaria	0.000846	0.0063	CcSEcCtD
Dapagliflozin—SLC5A2—NRF2 pathway—G6PD—malaria	0.000845	0.0253	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—G6PD—malaria	0.000845	0.0253	CbGpPWpGaD
Dapagliflozin—CYP2C9—hematopoietic system—malaria	0.000818	0.00828	CbGeAlD
Dapagliflozin—Urinary tract infection—Clindamycin—malaria	0.000806	0.00601	CcSEcCtD
Dapagliflozin—Angina pectoris—Quinidine barbiturate—malaria	0.000802	0.00598	CcSEcCtD
Dapagliflozin—Angina pectoris—Pentoxifylline—malaria	0.0008	0.00597	CcSEcCtD
Dapagliflozin—Renal failure—Quinine—malaria	0.000799	0.00596	CcSEcCtD
Dapagliflozin—Renal failure—Quinidine—malaria	0.000799	0.00596	CcSEcCtD
Dapagliflozin—ABCB1—blood plasma—malaria	0.000799	0.00808	CbGeAlD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—PKLR—malaria	0.000791	0.0237	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000789	0.0236	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000789	0.0236	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—HPGDS—malaria	0.000746	0.0224	CbGpPWpGaD
Dapagliflozin—Infestation NOS—Pentoxifylline—malaria	0.000733	0.00546	CcSEcCtD
Dapagliflozin—Infestation—Pentoxifylline—malaria	0.000733	0.00546	CcSEcCtD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC4A1—malaria	0.000725	0.0217	CbGpPWpGaD
Dapagliflozin—Renal failure—Quinidine barbiturate—malaria	0.000721	0.00538	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Quinidine—malaria	0.000721	0.00537	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Quinine—malaria	0.000721	0.00537	CcSEcCtD
Dapagliflozin—Urethral disorder—Quinidine—malaria	0.000716	0.00533	CcSEcCtD
Dapagliflozin—Urethral disorder—Quinine—malaria	0.000716	0.00533	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Sulfadiazine—malaria	0.00071	0.00529	CcSEcCtD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—G6PD—malaria	0.000705	0.0211	CbGpPWpGaD
Dapagliflozin—CYP1A1—kidney—malaria	0.000697	0.00705	CbGeAlD
Dapagliflozin—CYP2A6—brain—malaria	0.000675	0.00682	CbGeAlD
Dapagliflozin—Rash—Proguanil—malaria	0.000674	0.00503	CcSEcCtD
Dapagliflozin—Dermatitis—Proguanil—malaria	0.000674	0.00502	CcSEcCtD
Dapagliflozin—Headache—Proguanil—malaria	0.00067	0.00499	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Quinidine barbiturate—malaria	0.000651	0.00485	CcSEcCtD
Dapagliflozin—Urethral disorder—Quinidine barbiturate—malaria	0.000646	0.00481	CcSEcCtD
Dapagliflozin—Malnutrition—Quinine—malaria	0.000635	0.00474	CcSEcCtD
Dapagliflozin—Malnutrition—Quinidine—malaria	0.000635	0.00474	CcSEcCtD
Dapagliflozin—Nausea—Proguanil—malaria	0.000635	0.00474	CcSEcCtD
Dapagliflozin—Back pain—Clindamycin—malaria	0.000627	0.00467	CcSEcCtD
Dapagliflozin—CYP3A4—hematopoietic system—malaria	0.000624	0.00631	CbGeAlD
Dapagliflozin—CYP2D6—hematopoietic system—malaria	0.000614	0.00621	CbGeAlD
Dapagliflozin—Gastrointestinal disorder—Sulfadiazine—malaria	0.000613	0.00457	CcSEcCtD
Dapagliflozin—CYP1A2—digestive system—malaria	0.0006	0.00606	CbGeAlD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—PKLR—malaria	0.000599	0.018	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—PKLR—malaria	0.000599	0.018	CbGpPWpGaD
Dapagliflozin—CYP1A1—digestive system—malaria	0.000591	0.00598	CbGeAlD
Dapagliflozin—Angioedema—Quinidine—malaria	0.000581	0.00433	CcSEcCtD
Dapagliflozin—Angioedema—Quinine—malaria	0.000581	0.00433	CcSEcCtD
Dapagliflozin—Malnutrition—Quinidine barbiturate—malaria	0.000574	0.00427	CcSEcCtD
Dapagliflozin—CYP1A2—blood—malaria	0.000571	0.00578	CbGeAlD
Dapagliflozin—CYP2C9—digestive system—malaria	0.000569	0.00575	CbGeAlD
Dapagliflozin—Urticaria—Sulfadiazine—malaria	0.000564	0.0042	CcSEcCtD
Dapagliflozin—CYP1A1—blood—malaria	0.000563	0.0057	CbGeAlD
Dapagliflozin—Body temperature increased—Sulfadiazine—malaria	0.000561	0.00418	CcSEcCtD
Dapagliflozin—Hypertension—Clindamycin—malaria	0.000559	0.00417	CcSEcCtD
Dapagliflozin—Back pain—Pentoxifylline—malaria	0.000554	0.00413	CcSEcCtD
Dapagliflozin—Discomfort—Clindamycin—malaria	0.000545	0.00406	CcSEcCtD
Dapagliflozin—CYP2C9—blood—malaria	0.000542	0.00548	CbGeAlD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000537	0.004	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000537	0.004	CcSEcCtD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—G6PD—malaria	0.000534	0.016	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—G6PD—malaria	0.000534	0.016	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC4A1—malaria	0.000529	0.0158	CbGpPWpGaD
Dapagliflozin—Anaphylactic shock—Clindamycin—malaria	0.000529	0.00394	CcSEcCtD
Dapagliflozin—Angioedema—Quinidine barbiturate—malaria	0.000524	0.00391	CcSEcCtD
Dapagliflozin—Angioedema—Pentoxifylline—malaria	0.000523	0.0039	CcSEcCtD
Dapagliflozin—Hypersensitivity—Sulfadiazine—malaria	0.000523	0.0039	CcSEcCtD
Dapagliflozin—Oedema—Quinidine—malaria	0.000519	0.00387	CcSEcCtD
Dapagliflozin—Oedema—Quinine—malaria	0.000519	0.00387	CcSEcCtD
Dapagliflozin—CYP3A4—kidney—malaria	0.000511	0.00517	CbGeAlD
Dapagliflozin—Skin disorder—Quinidine—malaria	0.000504	0.00375	CcSEcCtD
Dapagliflozin—Skin disorder—Quinine—malaria	0.000504	0.00375	CcSEcCtD
Dapagliflozin—CYP2D6—kidney—malaria	0.000503	0.00509	CbGeAlD
Dapagliflozin—Hyperhidrosis—Quinidine—malaria	0.000501	0.00374	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Quinine—malaria	0.000501	0.00374	CcSEcCtD
Dapagliflozin—Hypertension—Pentoxifylline—malaria	0.000494	0.00368	CcSEcCtD
Dapagliflozin—Hypotension—Clindamycin—malaria	0.000494	0.00368	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000485	0.00361	CcSEcCtD
Dapagliflozin—Hypotension—Quinidine—malaria	0.000485	0.00361	CcSEcCtD
Dapagliflozin—Hypotension—Quinine—malaria	0.000485	0.00361	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000484	0.00361	CcSEcCtD
Dapagliflozin—Discomfort—Pentoxifylline—malaria	0.000482	0.00359	CcSEcCtD
Dapagliflozin—Oedema—Quinidine barbiturate—malaria	0.000468	0.00349	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Pentoxifylline—malaria	0.000467	0.00348	CcSEcCtD
Dapagliflozin—Oedema—Pentoxifylline—malaria	0.000467	0.00348	CcSEcCtD
Dapagliflozin—Infection—Pentoxifylline—malaria	0.000464	0.00346	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Clindamycin—malaria	0.000456	0.0034	CcSEcCtD
Dapagliflozin—Skin disorder—Quinidine barbiturate—malaria	0.000455	0.00339	CcSEcCtD
Dapagliflozin—Skin disorder—Pentoxifylline—malaria	0.000454	0.00338	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Quinidine barbiturate—malaria	0.000453	0.00337	CcSEcCtD
Dapagliflozin—Constipation—Clindamycin—malaria	0.000452	0.00337	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Pentoxifylline—malaria	0.000452	0.00337	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Quinine—malaria	0.000448	0.00334	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Quinidine—malaria	0.000448	0.00334	CcSEcCtD
Dapagliflozin—Rash—Sulfadiazine—malaria	0.000448	0.00334	CcSEcCtD
Dapagliflozin—Dermatitis—Sulfadiazine—malaria	0.000447	0.00333	CcSEcCtD
Dapagliflozin—CYP1A2—liver—malaria	0.000447	0.00452	CbGeAlD
Dapagliflozin—Headache—Sulfadiazine—malaria	0.000445	0.00331	CcSEcCtD
Dapagliflozin—ABCB1—hematopoietic system—malaria	0.000442	0.00447	CbGeAlD
Dapagliflozin—CYP1A1—liver—malaria	0.000441	0.00446	CbGeAlD
Dapagliflozin—Hypotension—Quinidine barbiturate—malaria	0.000437	0.00326	CcSEcCtD
Dapagliflozin—Hypotension—Pentoxifylline—malaria	0.000437	0.00325	CcSEcCtD
Dapagliflozin—UGT2B4—Biological oxidations—HPGDS—malaria	0.000437	0.0131	CbGpPWpGaD
Dapagliflozin—CYP3A4—digestive system—malaria	0.000434	0.00439	CbGeAlD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—DHFR—malaria	0.000433	0.013	CbGpPWpGaD
Dapagliflozin—Body temperature increased—Dapsone—malaria	0.000432	0.00322	CcSEcCtD
Dapagliflozin—CYP2D6—digestive system—malaria	0.000427	0.00432	CbGeAlD
Dapagliflozin—CYP2C9—liver—malaria	0.000424	0.00429	CbGeAlD
Dapagliflozin—Nausea—Sulfadiazine—malaria	0.000422	0.00314	CcSEcCtD
Dapagliflozin—Urticaria—Clindamycin—malaria	0.00042	0.00313	CcSEcCtD
Dapagliflozin—Body temperature increased—Clindamycin—malaria	0.000418	0.00311	CcSEcCtD
Dapagliflozin—CYP3A4—blood—malaria	0.000413	0.00418	CbGeAlD
Dapagliflozin—Urticaria—Quinidine—malaria	0.000412	0.00307	CcSEcCtD
Dapagliflozin—Urticaria—Quinine—malaria	0.000412	0.00307	CcSEcCtD
Dapagliflozin—Body temperature increased—Quinidine—malaria	0.00041	0.00306	CcSEcCtD
Dapagliflozin—Body temperature increased—Quinine—malaria	0.00041	0.00306	CcSEcCtD
Dapagliflozin—CYP2D6—blood—malaria	0.000407	0.00411	CbGeAlD
Dapagliflozin—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000404	0.00301	CcSEcCtD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000401	0.012	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000401	0.012	CbGpPWpGaD
Dapagliflozin—Constipation—Quinidine barbiturate—malaria	0.0004	0.00298	CcSEcCtD
Dapagliflozin—Constipation—Pentoxifylline—malaria	0.0004	0.00298	CcSEcCtD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000392	0.0117	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Clindamycin—malaria	0.00039	0.0029	CcSEcCtD
Dapagliflozin—Hypersensitivity—Quinine—malaria	0.000382	0.00285	CcSEcCtD
Dapagliflozin—Hypersensitivity—Quinidine—malaria	0.000382	0.00285	CcSEcCtD
Dapagliflozin—Urticaria—Quinidine barbiturate—malaria	0.000372	0.00277	CcSEcCtD
Dapagliflozin—Urticaria—Pentoxifylline—malaria	0.000371	0.00277	CcSEcCtD
Dapagliflozin—Body temperature increased—Quinidine barbiturate—malaria	0.00037	0.00276	CcSEcCtD
Dapagliflozin—Body temperature increased—Pentoxifylline—malaria	0.000369	0.00275	CcSEcCtD
Dapagliflozin—ABCB1—kidney—malaria	0.000362	0.00366	CbGeAlD
Dapagliflozin—Dizziness—Clindamycin—malaria	0.00035	0.00261	CcSEcCtD
Dapagliflozin—CYP1A1—brain—malaria	0.00035	0.00354	CbGeAlD
Dapagliflozin—Hypersensitivity—Quinidine barbiturate—malaria	0.000345	0.00257	CcSEcCtD
Dapagliflozin—Hypersensitivity—Pentoxifylline—malaria	0.000344	0.00257	CcSEcCtD
Dapagliflozin—Dizziness—Quinidine—malaria	0.000343	0.00256	CcSEcCtD
Dapagliflozin—Dizziness—Quinine—malaria	0.000343	0.00256	CcSEcCtD
Dapagliflozin—Headache—Dapsone—malaria	0.000342	0.00255	CcSEcCtD
Dapagliflozin—UGT2B7—Phase II conjugation—HPGDS—malaria	0.00034	0.0102	CbGpPWpGaD
Dapagliflozin—Rash—Clindamycin—malaria	0.000333	0.00248	CcSEcCtD
Dapagliflozin—Dermatitis—Clindamycin—malaria	0.000333	0.00248	CcSEcCtD
Dapagliflozin—Headache—Clindamycin—malaria	0.000331	0.00247	CcSEcCtD
Dapagliflozin—Rash—Quinidine—malaria	0.000327	0.00244	CcSEcCtD
Dapagliflozin—Rash—Quinine—malaria	0.000327	0.00244	CcSEcCtD
Dapagliflozin—Dermatitis—Quinine—malaria	0.000327	0.00244	CcSEcCtD
Dapagliflozin—Dermatitis—Quinidine—malaria	0.000327	0.00244	CcSEcCtD
Dapagliflozin—Headache—Quinine—malaria	0.000325	0.00242	CcSEcCtD
Dapagliflozin—Headache—Quinidine—malaria	0.000325	0.00242	CcSEcCtD
Dapagliflozin—Nausea—Dapsone—malaria	0.000325	0.00242	CcSEcCtD
Dapagliflozin—CYP3A4—liver—malaria	0.000323	0.00327	CbGeAlD
Dapagliflozin—CYP2D6—liver—malaria	0.000318	0.00322	CbGeAlD
Dapagliflozin—Nausea—Clindamycin—malaria	0.000314	0.00234	CcSEcCtD
Dapagliflozin—Dizziness—Quinidine barbiturate—malaria	0.00031	0.00231	CcSEcCtD
Dapagliflozin—Dizziness—Pentoxifylline—malaria	0.000309	0.0023	CcSEcCtD
Dapagliflozin—Nausea—Quinidine—malaria	0.000308	0.0023	CcSEcCtD
Dapagliflozin—Nausea—Quinine—malaria	0.000308	0.0023	CcSEcCtD
Dapagliflozin—ABCB1—digestive system—malaria	0.000307	0.00311	CbGeAlD
Dapagliflozin—UGT2B7—NRF2 pathway—G6PD—malaria	0.000297	0.00891	CbGpPWpGaD
Dapagliflozin—Rash—Quinidine barbiturate—malaria	0.000295	0.0022	CcSEcCtD
Dapagliflozin—Dermatitis—Quinidine barbiturate—malaria	0.000295	0.0022	CcSEcCtD
Dapagliflozin—Rash—Pentoxifylline—malaria	0.000295	0.0022	CcSEcCtD
Dapagliflozin—Dermatitis—Pentoxifylline—malaria	0.000294	0.00219	CcSEcCtD
Dapagliflozin—Headache—Quinidine barbiturate—malaria	0.000293	0.00219	CcSEcCtD
Dapagliflozin—Headache—Pentoxifylline—malaria	0.000293	0.00218	CcSEcCtD
Dapagliflozin—ABCB1—blood—malaria	0.000293	0.00296	CbGeAlD
Dapagliflozin—SLC5A4—Metabolism—DHODH—malaria	0.000291	0.00873	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000284	0.00852	CbGpPWpGaD
Dapagliflozin—ABCB1—bone marrow—malaria	0.000283	0.00286	CbGeAlD
Dapagliflozin—Nausea—Quinidine barbiturate—malaria	0.000278	0.00207	CcSEcCtD
Dapagliflozin—Nausea—Pentoxifylline—malaria	0.000278	0.00207	CcSEcCtD
Dapagliflozin—UGT1A9—Phase II conjugation—HPGDS—malaria	0.000276	0.00828	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000267	0.00799	CbGpPWpGaD
Dapagliflozin—CYP2D6—brain—malaria	0.000252	0.00255	CbGeAlD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—HPGDS—malaria	0.000249	0.00747	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—SLC4A1—malaria	0.000248	0.00742	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—G6PD—malaria	0.000242	0.00724	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—DECR1—malaria	0.000233	0.00698	CbGpPWpGaD
Dapagliflozin—ABCB1—liver—malaria	0.000229	0.00231	CbGeAlD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000225	0.00675	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PKLR—malaria	0.000224	0.00672	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—DHODH—malaria	0.000221	0.00661	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—DHODH—malaria	0.000221	0.00661	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—HBB—malaria	0.000211	0.00631	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—G6PD—malaria	0.0002	0.00599	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—HPGDS—malaria	0.000199	0.00596	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PKLR—malaria	0.000188	0.00562	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—SLC4A1—malaria	0.000188	0.00562	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—SLC4A1—malaria	0.000188	0.00562	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—G6PD—malaria	0.000186	0.00558	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000186	0.00557	CbGpPWpGaD
Dapagliflozin—ABCB1—brain—malaria	0.000182	0.00184	CbGeAlD
Dapagliflozin—SLC5A1—Metabolism—DECR1—malaria	0.000176	0.00529	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—DECR1—malaria	0.000176	0.00529	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—DHODH—malaria	0.00017	0.00511	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.00017	0.00509	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PKLR—malaria	0.00017	0.00509	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PKLR—malaria	0.00017	0.00509	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000169	0.00505	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—G6PD—malaria	0.000167	0.00501	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000163	0.00489	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—HPGDS—malaria	0.000162	0.00484	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—HBB—malaria	0.00016	0.00478	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—HBB—malaria	0.00016	0.00478	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000159	0.00476	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—CD36—malaria	0.000154	0.0046	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—G6PD—malaria	0.000151	0.00454	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—G6PD—malaria	0.000151	0.00454	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.00015	0.00451	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.00015	0.00449	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—SLC4A1—malaria	0.000145	0.00434	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000144	0.0043	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PKLR—malaria	0.000142	0.00426	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PKLR—malaria	0.000142	0.00426	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—DHFR—malaria	0.000141	0.00423	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—DECR1—malaria	0.000136	0.00408	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—CD36—malaria	0.000133	0.00399	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.00013	0.0039	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—HPGDS—malaria	0.000128	0.00382	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—G6PD—malaria	0.000127	0.0038	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—G6PD—malaria	0.000127	0.0038	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—HPGDS—malaria	0.000125	0.00373	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—HBB—malaria	0.000123	0.00369	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—DHFR—malaria	0.000118	0.00355	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—SCARB1—malaria	0.000117	0.00351	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL12B—malaria	0.000117	0.0035	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000113	0.00339	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PKLR—malaria	0.00011	0.00329	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000109	0.00327	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—DHFR—malaria	0.000107	0.00321	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—DHFR—malaria	0.000107	0.00321	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000101	0.00303	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	9.79e-05	0.00293	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—G6PD—malaria	9.79e-05	0.00293	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	9.68e-05	0.0029	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—HPGDS—malaria	9.67e-05	0.0029	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—HPGDS—malaria	9.67e-05	0.0029	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—HPGDS—malaria	9.28e-05	0.00278	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	8.98e-05	0.00269	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—DHFR—malaria	8.97e-05	0.00269	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—DHFR—malaria	8.97e-05	0.00269	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—SCARB1—malaria	8.88e-05	0.00266	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—SCARB1—malaria	8.88e-05	0.00266	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	8.64e-05	0.00259	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	8.6e-05	0.00258	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CD40LG—malaria	8.53e-05	0.00256	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL10—malaria	8.53e-05	0.00256	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL4—malaria	8.3e-05	0.00249	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—HLA-B—malaria	8.12e-05	0.00243	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—DHODH—malaria	7.76e-05	0.00233	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—FAS—malaria	7.65e-05	0.00229	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—CD36—malaria	7.65e-05	0.00229	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	7.55e-05	0.00226	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	7.48e-05	0.00224	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—HPGDS—malaria	7.47e-05	0.00224	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CD36—malaria	7.35e-05	0.0022	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—NOS2—malaria	7.22e-05	0.00216	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—HPGDS—malaria	6.98e-05	0.00209	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—DHFR—malaria	6.93e-05	0.00208	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—HPGDS—malaria	6.92e-05	0.00207	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—SCARB1—malaria	6.85e-05	0.00205	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	6.82e-05	0.00204	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SLC4A1—malaria	6.6e-05	0.00198	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—DECR1—malaria	6.5e-05	0.00195	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—DHODH—malaria	6.31e-05	0.00189	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	6.27e-05	0.00188	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malaria	6.27e-05	0.00188	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—DECR1—malaria	6.21e-05	0.00186	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.2e-05	0.00186	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	6.17e-05	0.00185	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—HPGDS—malaria	5.92e-05	0.00177	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.7e-05	0.00171	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—HBB—malaria	5.61e-05	0.00168	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CD36—malaria	5.57e-05	0.00167	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CD36—malaria	5.57e-05	0.00167	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	5.51e-05	0.00165	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	5.49e-05	0.00164	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NOS2—malaria	5.47e-05	0.00164	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NOS2—malaria	5.47e-05	0.00164	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SLC4A1—malaria	5.36e-05	0.00161	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CD4—malaria	5.35e-05	0.0016	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	5.25e-05	0.00157	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	5.16e-05	0.00154	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—DECR1—malaria	5.04e-05	0.00151	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IFNG—malaria	5.02e-05	0.0015	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PKLR—malaria	5e-05	0.0015	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DHODH—malaria	4.86e-05	0.00146	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	4.85e-05	0.00145	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—HPGDS—malaria	4.57e-05	0.00137	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—HBB—malaria	4.56e-05	0.00137	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL1B—malaria	4.48e-05	0.00134	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL2—malaria	4.46e-05	0.00134	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—G6PD—malaria	4.46e-05	0.00134	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CD36—malaria	4.3e-05	0.00129	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	4.15e-05	0.00124	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SLC4A1—malaria	4.13e-05	0.00124	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PKLR—malaria	4.06e-05	0.00122	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CD4—malaria	4.05e-05	0.00121	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CD4—malaria	4.05e-05	0.00121	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	4e-05	0.0012	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	4e-05	0.0012	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DECR1—malaria	3.89e-05	0.00116	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	3.77e-05	0.00113	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DHODH—malaria	3.62e-05	0.00109	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—G6PD—malaria	3.62e-05	0.00109	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CD36—malaria	3.57e-05	0.00107	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.56e-05	0.00107	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—HBB—malaria	3.52e-05	0.00105	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—HPGDS—malaria	3.4e-05	0.00102	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.27e-05	0.00098	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—malaria	3.25e-05	0.000973	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—DHFR—malaria	3.15e-05	0.000945	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PKLR—malaria	3.13e-05	0.000939	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SCARB1—malaria	3.12e-05	0.000935	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SLC4A1—malaria	3.08e-05	0.000923	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DECR1—malaria	2.9e-05	0.000868	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DHODH—malaria	2.89e-05	0.000867	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—malaria	2.89e-05	0.000866	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—G6PD—malaria	2.79e-05	0.000837	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—HPGDS—malaria	2.76e-05	0.000828	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DHODH—malaria	2.73e-05	0.000817	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DHODH—malaria	2.7e-05	0.00081	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.66e-05	0.000797	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HBB—malaria	2.62e-05	0.000785	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—DHFR—malaria	2.56e-05	0.000768	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SCARB1—malaria	2.54e-05	0.00076	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SLC4A1—malaria	2.46e-05	0.000737	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.44e-05	0.000731	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PKLR—malaria	2.33e-05	0.0007	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SLC4A1—malaria	2.32e-05	0.000695	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DECR1—malaria	2.31e-05	0.000693	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DHODH—malaria	2.31e-05	0.000692	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SLC4A1—malaria	2.3e-05	0.000689	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.27e-05	0.000681	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—malaria	2.19e-05	0.000656	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—malaria	2.19e-05	0.000656	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DECR1—malaria	2.18e-05	0.000653	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DECR1—malaria	2.16e-05	0.000648	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—HPGDS—malaria	2.13e-05	0.000638	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HBB—malaria	2.09e-05	0.000627	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.09e-05	0.000625	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—G6PD—malaria	2.08e-05	0.000623	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	2.05e-05	0.000615	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DHFR—malaria	1.98e-05	0.000592	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HBB—malaria	1.97e-05	0.000591	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC4A1—malaria	1.96e-05	0.000589	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CD36—malaria	1.96e-05	0.000587	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SCARB1—malaria	1.96e-05	0.000586	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HBB—malaria	1.95e-05	0.000586	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PKLR—malaria	1.86e-05	0.000559	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DECR1—malaria	1.85e-05	0.000553	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DHODH—malaria	1.78e-05	0.000534	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PKLR—malaria	1.76e-05	0.000527	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PKLR—malaria	1.74e-05	0.000522	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HBB—malaria	1.67e-05	0.0005	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—G6PD—malaria	1.66e-05	0.000498	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.6e-05	0.00048	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CD36—malaria	1.59e-05	0.000477	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HPGDS—malaria	1.59e-05	0.000475	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—G6PD—malaria	1.57e-05	0.000469	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—G6PD—malaria	1.55e-05	0.000465	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.53e-05	0.000459	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC4A1—malaria	1.52e-05	0.000454	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PKLR—malaria	1.49e-05	0.000446	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DHFR—malaria	1.47e-05	0.000441	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SCARB1—malaria	1.46e-05	0.000437	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DECR1—malaria	1.43e-05	0.000427	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—G6PD—malaria	1.33e-05	0.000398	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.31e-05	0.000392	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HBB—malaria	1.29e-05	0.000386	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HPGDS—malaria	1.27e-05	0.00038	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CD36—malaria	1.23e-05	0.000368	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HPGDS—malaria	1.19e-05	0.000358	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HPGDS—malaria	1.18e-05	0.000355	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DHFR—malaria	1.18e-05	0.000352	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SCARB1—malaria	1.16e-05	0.000349	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PKLR—malaria	1.15e-05	0.000344	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DHFR—malaria	1.11e-05	0.000332	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DHFR—malaria	1.1e-05	0.000329	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SCARB1—malaria	1.1e-05	0.000329	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SCARB1—malaria	1.09e-05	0.000326	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—G6PD—malaria	1.02e-05	0.000307	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HPGDS—malaria	1.01e-05	0.000303	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DHFR—malaria	9.39e-06	0.000281	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SCARB1—malaria	9.29e-06	0.000278	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CD36—malaria	9.14e-06	0.000274	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HPGDS—malaria	7.81e-06	0.000234	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CD36—malaria	7.3e-06	0.000219	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DHFR—malaria	7.24e-06	0.000217	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SCARB1—malaria	7.17e-06	0.000215	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CD36—malaria	6.88e-06	0.000206	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CD36—malaria	6.82e-06	0.000204	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CD36—malaria	5.83e-06	0.000175	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CD36—malaria	4.5e-06	0.000135	CbGpPWpGaD
